Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

ASTELLAS PHARMA INC (4503)

10
SummaryChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Astellas Pharma : Transfer of Distribution Rights for Targocid® and Maalox®

09/08/2011 | 10:10pm US/Eastern

Astellas Pharma Inc. (“Astellas Pharma”; Headquarters: Chuo-ku, Tokyo; President and CEO: Yoshihiko Hatanaka) and sanofi-aventis K.K. (“sanofi-aventis”; Headquarters: Shinjuku-ku, Tokyo; Representative Director and President: Jez Moulding) announced that Astellas Pharma will transfer the rights to distribute the injectable antibiotics Targocid® (generic name: teicoplanin) and the treatment for peptic ulcer and gastritis Maalox® (generic name: dried aluminum hydroxide gel and magnesium hydroxide) to sanofi-aventis effective on January 1, 2012. This transfer of distribution rights is taking place based on the expiration of the contract.

<Products for which distribution rights will be transferred>

React to this article
Latest news on ASTELLAS PHARMA INC
12/15 MEDIVATION : Data presented from phase 2 study of enzalutamide in advanced andro..
12/11 ENUMERAL BIOMEDICAL : Appoints Robert L. Van Nostrand to its Board of Directors
12/10 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Provide New Insights into ..
12/10 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Has Provided New Data on H..
12/10 ASTELLAS PHARMA : Data to be presented from phase 2 study of enzalutamide in adv..
12/08 ASTELLAS PHARMA : Named to FTSE4Good Sustainability Index for the Third Year
12/06 ASTELLAS PHARMA : to end license agreement with Janssen for ASP015K inhibitor
12/03 ASTELLAS PHARMA : New Findings from Astellas Pharma, Inc. in Tinea pedis Provide..
12/03 ASTELLAS PHARMA : Researchers at Astellas Pharma, Inc. Release New Data on Hemep..
12/02DJAbilify Maker Otsuka to Buy Avanir for $3.5 Billion
Advertisement
Chart
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF